Unit of PharmacoTherapy, -Epidemiology and -Economics, Groningen Research Institute of Pharmacy, University of Groningen, Groningen, The Netherlands.
GE Healthcare Radiopharmacy Zwolle, Zwolle, The Netherlands.
Drug Saf. 2020 Apr;43(4):319-328. doi: 10.1007/s40264-019-00895-2.
Radiopharmaceuticals may cause adverse events. Knowledge about adverse events from a patient's perspective could help healthcare professionals to detect, understand, and manage adverse events more efficiently when using radiopharmaceuticals. Researchers need a validated questionnaire that can be used in patients to assess adverse events with radiopharmaceuticals.
The aim of this study was to develop, validate the content of, and perform initial testing of a questionnaire assessing patient-reported adverse events of radiopharmaceuticals.
Based on existing literature, six professionals drafted and evaluated a first version of the questionnaire. Further content validation was performed using cognitive interviews with six patients undergoing a nuclear medicine examination. After adaptations, the questionnaire was developed into a web-based questionnaire. One hundred patients undergoing nuclear examination tested this version, and the results were used to assess its acceptability and evaluate reported adverse events.
Questions and answer options were revised in the initial questionnaire to improve clarity. In addition, some questions were removed. The final version consisted of 18 questions. In the test phase, the acceptability of the questionnaire was demonstrated (e.g. 79% of the patients who received the questionnaire completed it, and the median time to complete the questionnaire was 12 min for patients who reported an adverse event). Of the 100 patients (53% men, median age 64 years), 12 reported a total of 22 adverse events. One of these adverse events had a high causal association.
After validation and testing, the developed questionnaire to study patient-reported adverse events of radiopharmaceuticals is a suitable and valid instrument which can be used in future research.
放射性药物可能会引起不良反应。了解患者对不良反应的看法,可以帮助医疗保健专业人员在使用放射性药物时更有效地发现、理解和处理不良反应。研究人员需要一种经过验证的问卷,可以在患者中使用,以评估放射性药物的不良反应。
本研究旨在开发、验证和初步测试一种评估患者报告的放射性药物不良反应的问卷。
根据现有文献,六名专业人员起草并评估了问卷的初稿。进一步的内容验证采用了六名接受核医学检查的患者的认知访谈。经过调整,问卷被开发成一个基于网络的问卷。100 名接受核检查的患者测试了这个版本,结果用于评估其可接受性和评估报告的不良反应。
在初始问卷中,对问题和答案选项进行了修订,以提高清晰度。此外,还删除了一些问题。最终版本由 18 个问题组成。在测试阶段,问卷的可接受性得到了证明(例如,收到问卷的患者中有 79%完成了问卷,报告不良反应的患者完成问卷的中位数时间为 12 分钟)。在 100 名患者(53%为男性,中位年龄 64 岁)中,有 12 名患者报告了总共 22 起不良反应。其中一起不良反应有高度因果关系。
经过验证和测试,开发的研究放射性药物患者报告不良反应的问卷是一种合适和有效的工具,可用于未来的研究。